JPWO2023192506A5 - - Google Patents
Info
- Publication number
- JPWO2023192506A5 JPWO2023192506A5 JP2024557656A JP2024557656A JPWO2023192506A5 JP WO2023192506 A5 JPWO2023192506 A5 JP WO2023192506A5 JP 2024557656 A JP2024557656 A JP 2024557656A JP 2024557656 A JP2024557656 A JP 2024557656A JP WO2023192506 A5 JPWO2023192506 A5 JP WO2023192506A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- group
- aryl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263325852P | 2022-03-31 | 2022-03-31 | |
| US63/325,852 | 2022-03-31 | ||
| PCT/US2023/016941 WO2023192506A1 (en) | 2022-03-31 | 2023-03-30 | Malt1 modulators and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025511034A JP2025511034A (ja) | 2025-04-15 |
| JPWO2023192506A5 true JPWO2023192506A5 (https=) | 2026-02-26 |
| JP2025511034A5 JP2025511034A5 (https=) | 2026-02-26 |
Family
ID=86272082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557656A Pending JP2025511034A (ja) | 2022-03-31 | 2023-03-30 | Ｍａｌｔ１モジュレーターおよびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250326738A1 (https=) |
| EP (2) | EP4707276A2 (https=) |
| JP (1) | JP2025511034A (https=) |
| CN (1) | CN119032083A (https=) |
| AU (1) | AU2023243112A1 (https=) |
| CA (1) | CA3255659A1 (https=) |
| WO (1) | WO2023192506A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025003414A1 (en) | 2023-06-30 | 2025-01-02 | Janssen Pharmaceutica Nv | Malt1 inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| WO2018020474A1 (en) * | 2016-07-29 | 2018-02-01 | Lupin Limited | Substituted thiazolo-pyridine compounds as malt1 inhibitors |
| WO2019243964A1 (en) * | 2018-06-18 | 2019-12-26 | Janssen Pharmaceutica Nv | Pyrazole derivatives as malt1 inhibitors |
| WO2021138298A1 (en) * | 2019-12-30 | 2021-07-08 | Rheos Medicines, Inc. | Malt1 modulators and uses thereof |
-
2023
- 2023-03-30 CN CN202380030626.4A patent/CN119032083A/zh active Pending
- 2023-03-30 EP EP25223292.1A patent/EP4707276A2/en active Pending
- 2023-03-30 EP EP23720428.4A patent/EP4499611B1/en active Active
- 2023-03-30 JP JP2024557656A patent/JP2025511034A/ja active Pending
- 2023-03-30 AU AU2023243112A patent/AU2023243112A1/en active Pending
- 2023-03-30 CA CA3255659A patent/CA3255659A1/en active Pending
- 2023-03-30 US US18/850,955 patent/US20250326738A1/en active Pending
- 2023-03-30 WO PCT/US2023/016941 patent/WO2023192506A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021092115A5 (https=) | ||
| JP2025037925A5 (https=) | ||
| RU2014110623A (ru) | Пирролопиразиновые ингибиторы киназы | |
| JP2017088633A5 (https=) | ||
| RU2018138828A (ru) | Уменьшение массы опухоли путем введения ccr1 антагонистов в комбинации с pd-1 ингибиторами или pd-l1 ингибиторами | |
| JP2011046700A5 (https=) | ||
| JP2021534108A5 (https=) | ||
| JP2013533884A5 (https=) | ||
| JP2019529419A5 (https=) | ||
| JP2013522316A5 (https=) | ||
| JP2021522262A5 (https=) | ||
| JPWO2021187531A5 (https=) | ||
| JP2021528405A5 (https=) | ||
| JPWO2021030555A5 (https=) | ||
| JPWO2022241171A5 (https=) | ||
| JP2025160251A5 (https=) | ||
| JPWO2020232545A5 (https=) | ||
| JPWO2022212489A5 (https=) | ||
| JP2024072283A5 (https=) | ||
| JPWO2023192506A5 (https=) | ||
| JP2020533319A5 (https=) | ||
| RU2013143800A (ru) | Новое производное оксазолидиона и включающая его фармацевтическая композиция | |
| RU2019109570A (ru) | 8-(азетидин-1-ил)-[1,2,4]триазоло[1,5-а]пиридинилы, композиции и способы их применения | |
| JP2006515854A5 (https=) | ||
| JPWO2021262812A5 (https=) |